An osteoblast-dependent mechanism contributes to the leptin regulation of insulin secretion

Annals of the New York Academy of Sciences

Volumn 1173, Issue SUPPL. 1, 2009, Pages

  Hinoi, Eiichi ^a   Gao, Nan ^b   Jung, Dae Young ^c   Yadav, Vijay ^a   Yoshizawa, Tatsuya ^a   Kajimura, Daisuke ^a   Myers Jr , Martin G ^d   Chua Jr , Streamson C ^e   Wang, Qin ^f   Kim, Jason K ^c   Kaestner, Klaus H ^b   Karsenty, Gerard ^a  

^a Columbia University ^*  (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

leptin; osteoblast; osteocalcin

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; LEPTIN; OSTEOCALCIN; CLONIDINE; INSULIN; ISOPRENALINE; PHENYLEPHRINE;

BONE METABOLISM; BONE REMODELING; ENERGY METABOLISM; GENE DELETION; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; MOLECULAR GENETICS; NONHUMAN; OSTEOBLAST; PANCREAS ISLET BETA CELL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SYMPATHETIC INNERVATION; ADIPOCYTE; ANIMAL; ARTICLE; BONE; DRUG EFFECT; HOMEOSTASIS; INNERVATION; MOUSE; MOUSE MUTANT; NERVE CELL; PHYSIOLOGY; SECRETION;

ADIPOCYTES; ANIMALS; BONE AND BONES; BONE REMODELING; CLONIDINE; ENERGY METABOLISM; HOMEOSTASIS; INSULIN; INSULIN-SECRETING CELLS; ISOPROTERENOL; LEPTIN; MICE; MICE, OBESE; NEURONS; OSTEOBLASTS; PHENYLEPHRINE;

EID: 70350435713     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.05061.x     Document Type: Review

References (25)

1. Morioka, T., E. Asilmaz, J.Hu, et al. 2007. Disruption of leptin receptor expression in the pancreas directly affects beta cell growth and function in mice. J. Clin. Invest. 117: 2860-2868.
2. Covey, S.D., R.D. Wideman, C. McDonald, et al. 2006. The pancreatic beta cell is a key site for mediating the effects of leptin on glucose homeostasis. Cell Metab. 4: 291-302.
3. Kieffer, T.J. & J.F. Habener. 2000. The adipoinsular axis: effects of leptin on pancreatic betacells. Am. J. Physiol. Endocrinol. Metab. 278: E1-E14.
4. Spiegelman, B.M. & J.S. Flier. 1996. Adipogenesis and obesity: rounding out the big picture. Cell 87: 377-389.
5. Pelleymounter, M.A., M.J. Cullen, M.B. Baker, et al. 1995. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269: 540-543.
6. Moitra, J., M.M. Mason, M. Olive, et al. 1998. Life without white fat: a transgenic mouse. Genes Dev. 12: 3168-3181.
7. Farooqi, I.S., G. Matarese, G.M. Lord, et al. 2002. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J. Clin. Invest. 110: 1093-1103.
8. Grupe, A., B. Hultgren, A. Ryan, et al. 1995. Transgenic knockouts reveal a critical requirement for pancreatic beta cell glucokinase in maintaining glucose homeostasis. Cell 83: 69-78.
9. Rane, S.G., P.Dubus, R.V.Mettus, et al. 1999. Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia. Nat. Genet. 22: 44-52.
10. Björnholm, M., H. Münzberg, R.L. Leshan, et al. 2007. Mice Lacking inhibitory leptin receptor signals are lean with normal endocrine function. J. Clin. Invest. 117: 1354-1360.
11. Hummel, K.P., M.M. Dickie & D.L. Coleman. 1966. Diabetes, a new mutation in the mouse. Science 153: 1127-1128.
12. van de Wall, E. et al. 2008. Collective and individual functions of leptin receptor modulated neurons controlling metabolism and ingestion. Endocrinology 149: 1773-1785.
13. Takeda, S., F. Elefteriou, R. Levasseur, et al. 2002. Leptin regulates bone formation via the sympathetic nervous system. Cell 111: 305-317.
14. Satoh, N., Y. Ogawa, G. Katsuura, et al. 1999. Sympathetic activation of leptin via the ventromedial hypothalamus: leptin-induced increase in catecholamine secretion. Diabetes 48: 1787-1793.
15. Berthoud, H.R. & B. Jeanrenaud. 1979. Acute hyperinsulinemia and its reversal by vagotomy after lesions of the ventromedial hypothalamus in anesthetized rats. Endocrinology 105: 146-151.
16. Lee, N.K., H. Sowa, E. Hinoi, et al. 2007. Endocrine regulation of energy metabolism by the skeleton. Cell 130: 456-469.
17. Ferron, M.F., E. Hinoi, G. Karsenty & P. Ducy. 2008. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc. Natl. Acad. Sci. USA 105: 5266-5270.
18. Yang, X., K. Matsuda, P. Bialek, et al. 2004. ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome. Cell 117: 387-398.
19. Hay, C.W. & K. Docherty. 2006. Comparative analysis of insulin gene promoters: implications for diabetes research. Diabetes 55: 3201-3213.
20. Mayr, B. & M. Montminy. 2001. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat. Rev. Mol. Cell Biol. 2: 599-609.
21. Kim, H.I., J.Y. Cha, S.Y. Kim, et al. 2002. Peroxisomal proliferator-activated receptor-gamma upregulates glucokinase gene expression in beta-cells. Diabetes 51: 676-685.
22. Friedman, J.M. & J.L. Halaas. 1998. Leptin and the regulation of body weight in mammals. Nature 395: 763-770.
23. Elmquist, J.K., E. Maratos-Flier, C.B. Saper & J.S. Flier. 1998. Unraveling the central nervous system pathways underlying responses to leptin. Nat. Neurosci. 1: 445-450.
24. Karsenty, G. 2006. Convergence between bone and energy homeostases: leptin regulation of bone mass. Cell Metab. 4: 341-348.
25. Rosen, C.J. 2008. Bone remodeling, energy metabolism, and the molecular clock. Cell Metab. 7: 7-10.